Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Special Report
  • Published:

Animal intelligence

Use of animals for testing early in the drug-development process aims to provide vital information to make new drugs safe and effective — and the process is being constantly refined. Hannah Hoag finds out what is involved.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Author information

Author notes

  1. Hannah Hoag is a freelance writer based in Montreal, Canada.

    • Hannah Hoag
Authors

Related links

Related links

Related links in Nature Research

Drug hunt

Can super-antibody drugs be tamed?

In vivo drug discovery in the zebrafish

FDA Critical Path Initiative

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoag, H. Animal intelligence. Nature 441, 544–545 (2006). https://doi.org/10.1038/nj7092-544a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nj7092-544a

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing